|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1996)) |
| Withdrawn drug? | Yes |
IUPAC Name ![]() |
| 2-amino-5-oxo-7-(propan-2-yl)-5H-chromeno[2,3-b]pyridine-3-carboxylic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5950 | amlexanox |
Synonyms ![]() |
| AA-673 |
| Amlexanox® |
| Aphthasol® |
| CHX-3673 |
Database Links ![]() |
|
| CAS Registry No. | 68302-57-8 |
| ChEMBL Ligand | CHEMBL1096 |
| DrugBank Ligand | DB01025 |
| PubChem CID | 2161 |
| RCSB PDB Ligand | ANW |
| Search Google for chemical match using the InChIKey | SGRYPYWGNKJSDL-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | SGRYPYWGNKJSDL |
| Search PubMed clinical trials | amlexanox |
| Search PubMed titles | amlexanox |
| Search PubMed titles/abstracts | amlexanox |
| Wikipedia | Amlexanox |
| Comments |
| Amlexanox has anti-inflammatory [1], antiallergic and immunomodulatory actions [2]. Proposed to inhibit IKKδ and TBK1, albeit with low potency [5]. |